Publications
Detailed Information
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyung-Hun | - |
dc.contributor.author | Chang, Hye Jung | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.contributor.author | Kim, Sun Young | - |
dc.contributor.author | Lee, Keun-Wook | - |
dc.contributor.author | Kim, Jee Hyun | - |
dc.contributor.author | Hong, Yong Sang | - |
dc.contributor.author | Kim, Tae Won | - |
dc.contributor.author | Park, Young Suk | - |
dc.contributor.author | Kang, Won Ki | - |
dc.contributor.author | Shin, Sang Joon | - |
dc.contributor.author | Ahn, Joong Bae | - |
dc.contributor.author | Kang, Gyeong Hoon | - |
dc.contributor.author | Jeong, Seung-Yong | - |
dc.contributor.author | Park, Kyu Joo | - |
dc.contributor.author | Park, Jae-Gahb | - |
dc.contributor.author | Kim, Tae-You | - |
dc.date.accessioned | 2021-01-31T11:05:52Z | - |
dc.date.available | 2021-01-31T11:05:52Z | - |
dc.date.created | 2020-12-21 | - |
dc.date.created | 2020-12-21 | - |
dc.date.issued | 2013-04 | - |
dc.identifier.citation | Cancer Chemotherapy and Pharmacology, Vol.71 No.4, pp.843-851 | - |
dc.identifier.issn | 0344-5704 | - |
dc.identifier.other | 119329 | - |
dc.identifier.uri | https://hdl.handle.net/10371/173021 | - |
dc.description.abstract | Ethnic diversity of genetic polymorphism can result in individual differences in the efficacy and toxicity of cancer chemotherapy. We analyzed 20 germline polymorphisms in 10 genes (TS, MTHFR, ERCC1, XPD, XRCC1, ABCC2, AGXT, GSTP1, GSTT1 and GSTM1) from prospectively enrolled 292 Korean patients treated with adjuvant oxaliplatin plus leucovorin plus 5-fluorouracil (FOLFOX) for colon cancer. In contrast to previous studies in Caucasians, neutropenia (grade 3-4, 60.5 %) was frequently observed, whereas only 16.4 % experienced grade 2 or more sensory neuropathy. Neutropenia was more frequent in MTHFR 677TT [adjusted odds ratio (OR) 2.32, 95 % confidence interval (CI) 1.19-4.55] and ERCC1 19007TT (adjusted OR 4.58, 95 % CI 1.20-17.40) genotypes. Patients harboring XRCC1 23885GG experienced less grade 2-4 neuropathy [adjusted OR 0.52, 95 % CI 0.27-0.99]. MTHFR 677TT (p = 0.002) and XRCC1 23885GG (p = 0.146) genotypes were also more prevalent in Koreans compared to Caucasians. TS 'low' genotype (adjusted HR 1.83, 95 % CI 1.003-3.34) was significantly related to shorter disease-free survival. Overall survival was not significantly different according to the polymorphisms. Polymorphisms in MTHFR, XRCC1 and TS are related to toxicities and disease-free survival in patients with colon cancer. The ethnic differences in frequencies of genotypes may explain the ethnic difference in toxicity profile following adjuvant FOLFOX chemotherapy. | - |
dc.language | 영어 | - |
dc.publisher | Springer Verlag | - |
dc.title | Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1007/s00280-013-2075-3 | - |
dc.citation.journaltitle | Cancer Chemotherapy and Pharmacology | - |
dc.identifier.wosid | 000316745500002 | - |
dc.identifier.scopusid | 2-s2.0-84878950045 | - |
dc.citation.endpage | 851 | - |
dc.citation.number | 4 | - |
dc.citation.startpage | 843 | - |
dc.citation.volume | 71 | - |
dc.identifier.sci | 000316745500002 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.contributor.affiliatedAuthor | Lee, Keun-Wook | - |
dc.contributor.affiliatedAuthor | Kim, Jee Hyun | - |
dc.contributor.affiliatedAuthor | Kang, Gyeong Hoon | - |
dc.contributor.affiliatedAuthor | Jeong, Seung-Yong | - |
dc.contributor.affiliatedAuthor | Park, Kyu Joo | - |
dc.contributor.affiliatedAuthor | Park, Jae-Gahb | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | THYMIDYLATE SYNTHASE EXPRESSION | - |
dc.subject.keywordPlus | SINGLE NUCLEOTIDE POLYMORPHISM | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | GENETIC-POLYMORPHISM | - |
dc.subject.keywordPlus | GSTT1 POLYMORPHISMS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | OXALIPLATIN | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | FLUOROURACIL | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordAuthor | Adjuvant chemotherapy | - |
dc.subject.keywordAuthor | Colon cancer | - |
dc.subject.keywordAuthor | Oxaliplatin | - |
dc.subject.keywordAuthor | Polymorphism | - |
dc.subject.keywordAuthor | Toxicity | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.